Coherus Oncology (CHRS) Net Margin Growth (1y) (2014 - 2026)
Coherus Oncology (CHRS) Net Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Coherus Oncology |
199.14 Mn |
32.09 Mn |
8.50 Mn |
10,938.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
10,938.00 |
| Dec 31, 2025 |
12,780.00 |
| Sep 30, 2025 |
-53,120.00 |
| Jun 30, 2025 |
293,417.00 |
| Mar 31, 2025 |
-752,584.00 |
| Dec 31, 2024 |
2,751.00 |
| Sep 30, 2024 |
66,202.00 |
| Jun 30, 2024 |
48,026.00 |
| Mar 31, 2024 |
763,863.00 |
| Dec 31, 2023 |
4,278.00 |
| Sep 30, 2023 |
13,760.00 |
| Jun 30, 2023 |
1,036.00 |
| Mar 31, 2023 |
-7,364.00 |
| Dec 31, 2022 |
-45,873.00 |
| Sep 30, 2022 |
-14,406.00 |
| Jun 30, 2022 |
-4,924.00 |
| Mar 31, 2022 |
4,845.00 |
| Dec 31, 2021 |
32,207.00 |
| Sep 30, 2021 |
-7,233.00 |
| Jun 30, 2021 |
-8,019.00 |
